Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit

Repovic P, Burton E, Meng X, Meier D P, Barkhof F, Consortium of Multiple Sclerosis Centers Annual Meeting Presentations, 29 May 2015

Accessed on 8 Sep 2015 from https://cmsc.confex.com/cmsc/2015/webprogram/.